September 8, 2023

Inner Retinal Layer Changes and Ambulation Score in Multiple Sclerosis

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on Oct. 4, 2023 A recent study found that inner retinal layer atrophy, assessed using optical coherence tomography, was associated with worsening ambulation in patients with primary progressive multiple sclerosis. This indicates that optical coherence tomography can be utilized for monitoring disability progression in multiple sclerosis patients. Disability...

Placebo Response in Clinical Trials for Paroxetine for Vasomotor Symptoms

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on Oct. 4, 2023 This meta-analysis demonstrated that the majority of individuals taking paroxetine experienced a reduction in vasomotor symptoms (hot flashes); however, the same effect could be achieved by an inert placebo. The maximum true effect of paroxetine is estimated to be 32%. Vasomotor symptoms, including hot...

Peripheral B Cells in Pathophysiology and Diagnosis of Multiple Sclerosis

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on Oct. 4, 2023 Peripheral reactive B cells have a dual role in the pathogenesis and diagnosis of multiple sclerosis. These cells deliver myelin autoreactive antibodies to oligodendrocytes, which can also be a diagnostic biomarker in multiple sclerosis. Multiple sclerosis (MS) is characterized by a pathogenic immune response...

Gender and Menopause Effects on Obesity-Related Renal Inflammation and Lipotoxicity

Preliminary evidence shows that obesity may lead to renal inflammation and an unbalanced renal tissue lipidic profile, particularly after menopause. Obesity is a risk factor for chronic kidney disease (CKD). However, the prevalence of CKD has not increased in parallel with the obesity pandemic. It is important to identify the patients in whom obesity induces...

The Effects of Nitraria retusa Tea on Lipid Profiles

The findings of a preliminary investigation indicate that Nitraria retusa tea may be safe and effective for reducing serum cholesterol levels. Medications for reducing the risk of dyslipidemia have various side effects, highlighting the need for safer alternatives for prevention and treatment. One study showed that the Nitraria retusa plant inhibited cell differentiation in 3T3-L1...

The Association Between Polyunsaturated Fatty Acids and Asthma

This study found a negative association between asthma in children and the intake of docosahexaenoic acid in the diet, particularly in male children between 5 and 12 years of age with a history of maternal smoking during the gestation period.  The development of childhood asthma involves behavioral, genetic, and environmental changes. Polyunsaturated fatty acids (PUFA)...

Airway Challenge in Asthma: Systemic Responses and Cardiovascular Risk

Systemic inflammation and vascular function were not affected by immediate airway challenges involving bronchoconstriction (methacholine) or inflammation and bronchoconstriction (mannitol) in a recent clinical trial. Asthma is a persistent respiratory disorder characterized by repetitive instances of inflammation in the airways, leading to the constriction of the bronchial tubes and the manifestation of symptoms such as...

Dupilumab Effects on Eosinophilic Granulomatosis With Polyangiitis Onset in Adult Asthma

The administration of dupilumab is associated with an increased risk of the development of eosinophilic granulomatosis with polyangiitis in asthma patients with higher peripheral blood eosinophil counts. Dupilumab is a monoclonal antibody that acts against interleukin-4 receptor α (IL-4Rα), suppressing type 2 inflammation. Patients undergoing treatment with dupilumab may develop eosinophilia, characterized by a peripheral...

Long-Term Efficacy of Mepolizumab in Patients With Severe Asthma

This study demonstrated the long-term efficacy of mepolizumab, a monoclonal interleukin-5 antibody, in reducing asthma exacerbations, steroid dependence, and nasal polyps over a 3-year period. Mepolizumab (MEP) is a monoclonal antibody that acts against interleukin (IL)-5 to control the proliferation, maturation, and activity of eosinophils. The efficacy of MEP in patients with severe asthma has...

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.